Lataa...
Biologics as countermeasures for acute radiation syndrome: where are we now?
Despite significant scientific advances toward the development of a safe, nontoxic and effective radiation countermeasure for acute radiation syndrome (ARS) over the past six decades, no drug has been approved by the US FDA. Several biologics are currently under development as radiation countermeasu...
Tallennettuna:
| Julkaisussa: | Expert Opin Biol Ther |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Informa Healthcare
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4720033/ https://ncbi.nlm.nih.gov/pubmed/25416452 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14712598.2015.986453 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|